Cargando…
Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
Sample sizes for single-period clinical trials, including pharmacokinetic studies, are statistically determined by within-subject variability (WSV). However, it is difficult to determine WSV without replicate-designed clinical trial data, and statisticians typically estimate optimal sample sizes usi...
Autores principales: | Kang, Won-ho, Lee, Jae-yeon, Chae, Jung-woo, Lee, Kyeong-Ryoon, Baek, In-hwan, Kim, Min-Soo, Back, Hyun-moon, Jung, Sangkeun, Shaffer, Craig, Savic, Rada, Yun, Hwi-yeol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913178/ https://www.ncbi.nlm.nih.gov/pubmed/33546114 http://dx.doi.org/10.3390/ph14020114 |
Ejemplares similares
-
Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine
por: Ngo, Lien Thi, et al.
Publicado: (2022) -
Fine-tuning of BERT Model to Accurately Predict Drug–Target Interactions
por: Kang, Hyeunseok, et al.
Publicado: (2022) -
The Effect of CYP2D6 Phenotypes on the Pharmacokinetics of Propafenone: A Systematic Review and Meta-Analysis
por: Tran, Quyen Thi, et al.
Publicado: (2022) -
Fractal Kinetic Implementation in Population Pharmacokinetic Modeling
por: Jung, Woojin, et al.
Publicado: (2023) -
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor‐Mediated Recycling of HL2351, a Novel Hybrid Fc‐Fused Interleukin‐1 Receptor Antagonist, to Optimize Dosage Regimen
por: Ngo, Lien, et al.
Publicado: (2020)